The European Foundation for the Care of Newborn Infants (EFCNI) is a pan-European organisation representing parents and scientific experts with the aim of improving the long-term care of preterm and newborn infants with illnesses and support for their families.

EFCNI seeks to ensure that Europe's largest group of child patients receives the attention it deserves.

EFCNI was set up in April 2008. It is the first time that people from diverse disciplines, who are all involved in the care for newborn infants and particularly preterm infants, have come together at European level.

EFCNI encourages all those involved or interested in this issue to interact and exchange ideas. It promotes mutual understanding and serves as a platform for the initiation, coordination and integration of all local, national and international activities involving the care of newborn infants, prevention of preterm delivery, long-term care of preterm infants and support for parents and relatives. EFCNI is particularly keen to establish a link between parents, health professionals and scientists.  

We want to pay our respect and gratitude to all of the giant leaders and companies that have participated in raising funds organization to help out the development and innovations in taking care of the prematurely born babies. We also want to acknowledge the effort of big Canadian brands in the gambling industry to find a creative and entertaining way to participate. They were more than generous in hosting special tournament events and donating large amounts of their profits. If you want to join in and help our organization even a little bit, then all you need is to use this exclusive bonus deal of 100% up to 100$ + 20 spins and start. Now you can have fun and help at the same time. We are fighting for the noblest and human cause - we are fighting for sustaining a new life.


Dräger is an international leader in the fields of medical and safety technology. The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for preterm infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.